Stocks Weight-loss drug Zepbound eliminates sleep apnea in 52% of patients, Lilly says From ReutersJune 22, 2024 Patrick Wingrove (Reuters) – Eli Lilly (NYSE:) on Friday said its popular weight loss drug…
Stocks Some doses of Lilly’s Zepbound will remain in short supply until the end of April, according to the US FDA. From ReutersApril 3, 2024 Risk Disclosure: Trading financial instruments and/or cryptocurrencies involves high risks, including the risk of losing…
